[Strong and sustained-acting triptan. Therewith migraine does not return soon].
D000284:Administration, Oral; D002986:Clinical Trials as Topic; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008881:Migraine Disorders / Q000188:drug therapy*; D010919:Placebos; D011759:Pyrrolidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012008:Recurrence; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018170:Sumatriptan / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D014363:Tryptamines; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000627:therapeutic use
D007211:Indoles; D010919:Placebos; D011759:Pyrrolidines; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; D014662:Vasoconstrictor Agents; C115647:eletriptan; D018170:Sumatriptan